Enzon Pharmaceuticals Alpha and Beta Analysis
| ENZNDelisted Stock | USD 0.20 0.01 5.26% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Enzon Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Enzon Pharmaceuticals over a specified time horizon. Remember, high Enzon Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Enzon Pharmaceuticals' market risk premium analysis include:
Beta 0.28 | Alpha 0.12 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Enzon |
Enzon Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Enzon Pharmaceuticals market risk premium is the additional return an investor will receive from holding Enzon Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Enzon Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Enzon Pharmaceuticals' performance over market.| α | 0.12 | β | 0.28 |
Enzon Pharmaceuticals Fundamentals Vs Peers
Comparing Enzon Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Enzon Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Enzon Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Enzon Pharmaceuticals or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Enzon Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Enzon Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Enzon Pharmaceuticals to competition |
| Fundamentals | Enzon Pharmaceuticals | Peer Average |
| Return On Equity | -0.016 | -0.31 |
| Return On Asset | -0.0138 | -0.14 |
| Operating Margin | (36.28) % | (5.51) % |
| Current Valuation | 17.63 M | 16.62 B |
| Shares Outstanding | 74.21 M | 571.82 M |
| Shares Owned By Insiders | 10.70 % | 10.09 % |
| Shares Owned By Institutions | 48.58 % | 39.21 % |
Enzon Pharmaceuticals Opportunities
Enzon Pharmaceuticals Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Enzon Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Enzon or other otcs. Alpha measures the amount that position in Enzon Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Enzon Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Enzon Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Enzon Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Enzon Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Enzon Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Enzon Pharmaceuticals' management manipulating its earnings.
| 15th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Enzon Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Enzon Pharmaceuticals information on this page should be used as a complementary analysis to other Enzon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Enzon OTC Stock
If you are still planning to invest in Enzon Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enzon Pharmaceuticals' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |